New Key Statistics Module, Z-Score and F-Score
NAS:AGIO Key Ratios
| Market Cap $ M | 1,893.95 |
| Enterprise Value $ M | 1,336.20 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 2.54 |
| Price/Sales | 63.43 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 29.00 |
| EPS (TTM) $ | -6.32 |
| Beneish M-Score | -2.27 |
| 10-y EBITDA Growth Rate % | -12.40 |
| 5-y EBITDA Growth Rate % | -5.70 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -3.40 |
| EV-to-EBITDA | -3.45 |
| PEG | -- |
| Shares Outstanding M | 56.77 |
| Net Margin (%) | -1,199.26 |
| Operating Margin % | -1,336.42 |
| Pre-tax Margin (%) | -1,199.26 |
| Quick Ratio | 12.39 |
| Current Ratio | 12.84 |
| ROA % (ttm) | -35.05 |
| ROE % (ttm) | -39.69 |
| ROIC % (ttm) | -136.94 |
| Dividend Yield % | -- |
| Altman Z-Score | 8.67 |
AGIO Number of Guru Trades
AGIO Volume of Guru Trades
Gurus Latest Trades with NAS:AGIO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:AGIO is held by these investors
Total 1
Agios Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:AGIO
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers